241 related articles for article (PubMed ID: 16252244)
21. Association of Oligoadenylate Synthetase Gene Cluster and DC-SIGN (CD209) Gene Polymorphisms with Clinical Symptoms in Chikungunya Virus Infection.
Chaaithanya IK; Muruganandam N; Surya P; Anwesh M; Alagarasu K; Vijayachari P
DNA Cell Biol; 2016 Jan; 35(1):44-50. PubMed ID: 26398832
[TBL] [Abstract][Full Text] [Related]
22. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population.
Rebbani K; Ezzikouri S; Marchio A; Ababou M; Kitab B; Dejean A; Kandil M; Pineau P; Benjelloun S
Infect Genet Evol; 2014 Aug; 26():1-7. PubMed ID: 24797387
[TBL] [Abstract][Full Text] [Related]
23. Association between polymorphisms in OAS2 and CD209 genes and predisposition to chronic hepatitis C in Russian population.
Barkhash AV; Kochneva GV; Chub EV; Mikhailova SV; Romaschenko AG
Microbes Infect; 2014 May; 16(5):445-9. PubMed ID: 24594345
[TBL] [Abstract][Full Text] [Related]
24. Chimpanzee DC-SIGN alleles predict the existence of A and B isoforms, but do not support a role for resistance to HIV infection.
Santos PR; Michel-Salzat A; Butor C
AIDS Res Hum Retroviruses; 2005 Sep; 21(9):820-9. PubMed ID: 16218808
[TBL] [Abstract][Full Text] [Related]
25. Towards a crucial role for DC-SIGN in tuberculosis and beyond.
Neyrolles O; Gicquel B; Quintana-Murci L
Trends Microbiol; 2006 Sep; 14(9):383-7. PubMed ID: 16876999
[TBL] [Abstract][Full Text] [Related]
26. Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment outcomes: a Moroccan cohort study.
Fayssel N; Bensghir R; Ouladlahsen A; Abdelghaffar H; Sodqi M; Lahlou K; Benjelloun S; Marhoum El Filali K; Ezzikouri S; Wakrim L
Clin Microbiol Infect; 2015 May; 21(5):513.e1-5. PubMed ID: 25656622
[TBL] [Abstract][Full Text] [Related]
27. Differential gene expression profiles of human monocyte-derived antigen presenting cells in response to Penicillium marneffei: roles of DC-SIGN (CD209) in fungal cell uptake.
Ngaosuwankul P; Pongtanalert P; Engering A; Chaiyaroj SC
Asian Pac J Allergy Immunol; 2008; 26(2-3):151-63. PubMed ID: 19054934
[TBL] [Abstract][Full Text] [Related]
28. Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation.
Mezger M; Steffens M; Semmler C; Arlt EM; Zimmer M; Kristjanson GI; Wienker TF; Toliat MR; Kessler T; Einsele H; Loeffler J
Clin Microbiol Infect; 2008 Mar; 14(3):228-34. PubMed ID: 18076668
[TBL] [Abstract][Full Text] [Related]
29. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
[TBL] [Abstract][Full Text] [Related]
30. Identification and molecular profiling of DC-SIGN-like from big belly seahorse (Hippocampus abdominalis) inferring its potential relevancy in host immunity.
Jo E; Elvitigala DAS; Wan Q; Oh M; Oh C; Lee J
Dev Comp Immunol; 2017 Dec; 77():270-279. PubMed ID: 28867209
[TBL] [Abstract][Full Text] [Related]
31. [Natural selection of DC-SIGN and its homologues L-SIGN and mSIGNR1 in pathogen recognition and innate immunity].
Quintana-Murci L
Med Sci (Paris); 2006 Jan; 22(1):29-32. PubMed ID: 16386217
[No Abstract] [Full Text] [Related]
32. A variant in the CD209 promoter is associated with severity of dengue disease.
Sakuntabhai A; Turbpaiboon C; Casadémont I; Chuansumrit A; Lowhnoo T; Kajaste-Rudnitski A; Kalayanarooj SM; Tangnararatchakit K; Tangthawornchaikul N; Vasanawathana S; Chaiyaratana W; Yenchitsomanus PT; Suriyaphol P; Avirutnan P; Chokephaibulkit K; Matsuda F; Yoksan S; Jacob Y; Lathrop GM; Malasit P; Desprès P; Julier C
Nat Genet; 2005 May; 37(5):507-13. PubMed ID: 15838506
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the relationship between single nucleotide polymorphism of the CD209, IL-10, IL-28 and CCR5 D32 genes with the human predisposition to developing tick-borne encephalitis.
Czupryna P; Parczewski M; Grygorczuk S; Pancewicz S; Zajkowska J; Dunaj J; Kondrusik M; Krawczuk K; Moniuszko-Malinowska A
Postepy Hig Med Dosw (Online); 2017 Jan; 71(1):788-796. PubMed ID: 28894041
[TBL] [Abstract][Full Text] [Related]
34. Determination of DC-SIGN and DC-SIGNR repeat region variations.
Liu H; Zhu T
Methods Mol Biol; 2005; 304():471-81. PubMed ID: 16061998
[TBL] [Abstract][Full Text] [Related]
35. Association of promoter region polymorphisms of CD209 gene with clinical outcomes of dengue virus infection in Western India.
Alagarasu K; Damle IM; Bachal RV; Mulay AP; Shah PS; Dayaraj C
Infect Genet Evol; 2013 Jul; 17():239-42. PubMed ID: 23624202
[TBL] [Abstract][Full Text] [Related]
36. Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis.
Léger P; Tetard M; Youness B; Cordes N; Rouxel RN; Flamand M; Lozach PY
Traffic; 2016 Jun; 17(6):639-56. PubMed ID: 26990254
[TBL] [Abstract][Full Text] [Related]
37. [Innate immunity and human diseases: from archaic introgression to natural selection].
Deschamps M; Quintana-Murci L
Med Sci (Paris); 2016 Dec; 32(12):1079-1086. PubMed ID: 28044971
[TBL] [Abstract][Full Text] [Related]
38. Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
Ryan EJ; Dring M; Ryan CM; McNulty C; Stevenson NJ; Lawless MW; Crowe J; Nolan N; Hegarty JE; O'Farrelly C
Hum Immunol; 2010 Aug; 71(8):829-32. PubMed ID: 20470843
[TBL] [Abstract][Full Text] [Related]
39. CD209-336A/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients.
Afifi RA; Kamal D; Sayed RE; Ekladious SMM; Shaheen GH; Yousry SM; Hussein RE
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):75-81. PubMed ID: 29100978
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a monoclonal antibody specific for bovine CD209.
Park KT; Burnett S; Davis WC
Vet Immunol Immunopathol; 2015 Feb; 163(3-4):216-20. PubMed ID: 25593043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
